Two different mechanisms of serum resistance in Escherichia coli

Microbial Pathogenesis

Volumn 5, Issue 5, 1988, Pages 371-379

  Kubens, Britta S ^a   Wettstein, Mathias ^a   Opferkuch, Wolfgang ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

E. coli virulence; mechanisms of serum resistance; serum resistance

Indexed keywords

COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C6;

ANTIBIOTIC RESISTANCE; ESCHERICHIA COLI; NONHUMAN;

BLOOD; COMPLEMENT; CULTURE MEDIA; ESCHERICHIA COLI; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; SPECIES SPECIFICITY; SUPPORT, NON-U.S. GOV'T; VIRULENCE;

EID: 0024243278     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/0882-4010(88)90037-X     Document Type: Article

References (37)

1. The membrane attack complex of complement
2. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death
3. Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of the Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane
4. Complement and bacteria: chemistry and biology in host defense
5. Activation of complement by serum-resistant Neisseria gonorrhoeae. Assembly of the membrane attack complex without subsequent cell death
6. Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing
7. Role of E. coli K capsular antigens during complement activation, C3 fixation, and opsonization
8. Modulation of the alternative complement pathway by β1H globulin
9. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein β1H for cleavage of C3b and C4b in solution
10. Modulation of C3b hemolytic activity by a plasma protein distinct from C3b inactivator
11. Complement C3 convertase: cell surface restriction of β1H control and generation of restriction on neuraminidase-treated cells
12. Bacterial capsule—old dogmas and new tricks
13. Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation
14. Control of the amplification convertase of complement by the plasma protein β1H
15. Interaction of β1H globulin with cell-bound C3b: quantitative analysis of binding and influence of alternative pathway components on binding
16. Reaction mechanism of β1H globulin
17. Molecular interactions of the control proteins C3b inactivator and β1H with various complement intermediates
18. Human alternative complement pathway, membrane-associated sialic acid regulates the competition between B and β1H for cell-bound C3b
19. The interaction of C5 with C3b in free solution: a sufficient condition for cleavage by a fluid phase C3/C5 convertase
20. Inhibition of classical C5 convertase in the complement system by factor H
21. K antigens of Escherichia coli and renal involvement in urinarytract infections
22. K1 antigen-associated resistance to the bactericidal activity of serum
23. The role of capsular antigens in serum resistance and in vivo virulence of Escherichia coli
24. Role of lipopolysaccharide and capsule in the serum resistance of bacteremic strains of Escherichia coli
25. E. coli K antigen in relation to serum-induced lysis and phagocytosis
26. The importance of the K1 capsule in invasive infections caused by Escherichia coli
27. Role of the capsule and the O antigen in resistance of O18:K1 Escherichia coli to complement-mediated killing
28. Degree of antibody-independent activation of the classical complement pathway by K1 Escherichia coli differs with O antigen type and correlates with virulence of meningitis in newborns
29. Some physical properties of K antigens of E. coli related to their biological activity
30. The virulence for mice of strains of E. coli related to the effects of K antigens on their resistance to phagocytosis and killing by complement
31. Determination of pathogenicity of E. coli KL1
32. K-1 antigen content and the presence of an additional sialic acid-containing antigen among bacteremic K-1 Escherichia coli: correlation with susceptibility to opsonophagocytosis
33. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetra-chloror-3a,6a-diphenyl-glycoluril
34. Complement and complement fixation
35. Kinetic assay for the determination of the hemolytic activity of the complement system via the alternative pathway